FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Limbird, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limbird, L. E.

The FASEB Journal, Vol 2, 2686-2695, Copyright © 1988 by The Federation of American Societies for Experimental Biology

REVIEWS

Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms

LE Limbird
Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232.

Many hormones and neurotransmitters attenuate cyclic AMP (cAMP) accumulation in intact cells by virtue of their ability to inhibit adenylate cyclase activity via the GTP-binding protein denoted as Gi. Nonetheless, a number of physiological findings suggest that attenuation of cAMP production is not sufficient to serve as the only signal for eliciting the diverse physiological effects provoked by these various receptor populations. Additional biochemical and electrophysiological changes are known to occur after occupancy of receptors linked to inhibition of adenylate cyclase, including acceleration of Na+/H+ exchange, activation of K+ conductances, and inhibition of voltage-sensitive Ca2+ channels. This review summarizes the current understanding of how these receptors are coupled to their multiple potential effector mechanisms and offers some speculation about the possible interplay between the biochemical and electrophysiological sequels of receptor occupancy. It is hoped that future studies will establish which constellation of possible signaling mechanisms actually brings about changes in metabolic, secretory, or contractile events in different target cells.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Xu, Y. Chen, R. Lu, C. Cottingham, K. Jiao, and Q. Wang
Protein Kinase A Phosphorylation of Spinophilin Modulates Its Interaction with the {alpha}2A-Adrenergic Receptor (AR) and Alters Temporal Properties of {alpha}2AAR Internalization
J. Biol. Chem., May 23, 2008; 283(21): 14516 - 14523.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
X. Hu, D. Friedman, S. Hill, R. Caprioli, W. Nicholson, A. C Powers, L. Hunter, and L. E Limbird
Proteomic exploration of pancreatic islets in mice null for the {alpha}2A adrenergic receptor
J. Mol. Endocrinol., August 1, 2005; 35(1): 73 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
A. E. Brady, Q. Wang, P. B. Allen, M. Rizzo, P. Greengard, and L. E. Limbird
{alpha}2-Adrenergic Agonist Enrichment of Spinophilin at the Cell Surface Involves {beta}{gamma} Subunits of Gi Proteins and Is Preferentially Induced by the {alpha}2A-Subtype
Mol. Pharmacol., May 1, 2005; 67(5): 1690 - 1696.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. S. Pao and J. L. Benovic
Structure/Function Analysis of {alpha}2A-Adrenergic Receptor Interaction with G Protein-coupledReceptor Kinase 2
J. Biol. Chem., March 25, 2005; 280(12): 11052 - 11058.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. A. Jordan, I. Gomes, C Rios, J. Filipovska, and L. A. Devi
Functional Interactions between {micro} Opioid and {alpha}2A-Adrenergic Receptors
Mol. Pharmacol., December 1, 2003; 64(6): 1317 - 1324.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. E. Brady, Q. Wang, R. J. Colbran, P. B. Allen, P. Greengard, and L. E. Limbird
Spinophilin Stabilizes Cell Surface Expression of {alpha}2B-Adrenergic Receptors
J. Biol. Chem., August 22, 2003; 278(34): 32405 - 32412.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. J. Pauwels, I. Rauly, and T. Wurch
Dissimilar Pharmacological Responses by a New Series of Imidazoline Derivatives at Precoupled and Ligand-Activated {alpha}2A-Adrenoceptor States: Evidence for Effector Pathway-Dependent Differential Antagonism
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1015 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. G. Wilson, S. B. Smith, E. J. Chesler, K. A. Melton, J. J. Haas, B. Mitton, K. Strasburg, L. Hubert, S. L. Rodriguez-Zas, and J. S. Mogil
The Heritability of Antinociception: Common Pharmacogenetic Mediation of Five Neurochemically Distinct Analgesics
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 547 - 559.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. A. Blednov, M. Stoffel, H. Alva, and R. A. Harris
A pervasive mechanism for analgesia: Activation of GIRK2 channels
PNAS, January 7, 2003; 100(1): 277 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. E. Weatherby, B. S. Zwilling, and W. P. Lafuse
Resistance of Macrophages to Mycobacterium avium Is Induced by {alpha}2-Adrenergic Stimulation
Infect. Immun., January 1, 2003; 71(1): 22 - 29.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Wang and L. E. Limbird
Regulated Interactions of the alpha 2A Adrenergic Receptor with Spinophilin, 14-3-3zeta , and Arrestin 3
J. Biol. Chem., December 20, 2002; 277(52): 50589 - 50596.
[Abstract] [Full Text] [PDF]

Home page
 Mol Biol EvolHome page
O. Madsen, D. Willemsen, B. M. Ursing, U. Arnason, and W. W. de Jong
Molecular Evolution of the Mammalian Alpha 2B Adrenergic Receptor
Mol. Biol. Evol., December 1, 2002; 19(12): 2150 - 2160.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. L. DeGraff, V. V. Gurevich, and J. L. Benovic
The Third Intracellular Loop of alpha 2-Adrenergic Receptors Determines Subtype Specificity of Arrestin Interaction
J. Biol. Chem., November 1, 2002; 277(45): 43247 - 43252.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
L. J. Vogt, L. J. Sim-Selley, S. R. Childers, R. G. Wiley, and B. A. Vogt
Colocalization of {micro}-Opioid Receptors and Activated G-Proteins in Rat Cingulate Cortex
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 840 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. C. Jeyaraj, M. A. Chotani, S. Mitra, H. E. Gregg, N. A. Flavahan, and K. J. Morrison
Cooling Evokes Redistribution of alpha 2C-Adrenoceptors from Golgi to Plasma Membrane in Transfected Human Embryonic Kidney 293 Cells
Mol. Pharmacol., December 1, 2001; 60(6): 1195 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. R. M. Russell and D. E. Potter
Biphasic Alterations of cAMP Levels and Inhibition of Norepinephrine Release in Iris-Ciliary Body by Bremazocine
J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 941 - 946.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
K. A. Neve, M. G. Cumbay, K. R. Thompson, R. Yang, D. C. Buck, V. J. Watts, C. J. DuRand, and M. M. Teeter
Modeling and Mutational Analysis of a Putative Sodium-Binding Pocket on the Dopamine D2 Receptor
Mol. Pharmacol., August 1, 2001; 60(2): 373 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
S. Guimaraes and D. Moura
Vascular Adrenoceptors: An Update
Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. H. Wilson, H. A. Highfield, and L. E. Limbird
The Role of a Conserved Inter-Transmembrane Domain Interface in Regulating {alpha}2a-Adrenergic Receptor Conformational Stability and Cell-Surface Turnover
Mol. Pharmacol., April 1, 2001; 59(4): 929 - 938.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
H. Schaffhauser, Z. Cai, F. Hubalek, T. A. Macek, J. Pohl, T. J. Murphy, and P. J. Conn
cAMP-Dependent Protein Kinase Inhibits mGluR2 Coupling to G-Proteins by Direct Receptor Phosphorylation
J. Neurosci., August 1, 2000; 20(15): 5663 - 5670.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. J. Pauwels, S. Tardif, T. Wurch, and F. C. Colpaert
Facilitation of Constitutive alpha 2A-Adrenoceptor Activity by Both Single Amino Acid Mutation (Thr373Lys) and Galpha o Protein Coexpression: Evidence for Inverse Agonism
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 654 - 663.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
N. L. Schramm and L. E. Limbird
Stimulation of Mitogen-activated Protein Kinase by G Protein-coupled alpha 2-Adrenergic Receptors Does Not Require Agonist-elicited Endocytosis
J. Biol. Chem., August 27, 1999; 274(35): 24935 - 24940.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Prezeau, J. G. Richman, S. W. Edwards, and L. E. Limbird
The zeta  Isoform of 14-3-3 Proteins Interacts with the Third Intracellular Loop of Different alpha 2-Adrenergic Receptor Subtypes
J. Biol. Chem., May 7, 1999; 274(19): 13462 - 13469.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. A. Macek, H. Schaffhauser, and P. J. Conn
Protein Kinase C and A3 Adenosine Receptor Activation Inhibit Presynaptic Metabotropic Glutamate Receptor (mGluR) Function and Uncouple mGluRs from GTP-Binding Proteins
J. Neurosci., August 15, 1998; 18(16): 6138 - 6146.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Liang, M. G. Eason, E. A. Jewell-Motz, M. A. Williams, C. T. Theiss, G. W. Dorn II, and S. B. Liggett
Phosphorylation and Functional Desensitization of the alpha 2A-Adrenergic Receptor by Protein Kinase C
Mol. Pharmacol., July 1, 1998; 54(1): 44 - 49.
[Abstract] [Full Text]

Home page
 Pharmacol. Rev.Home page
M. C. Michel, A. Beck-Sickinger, H. Cox, H. N. Doods, H. Herzog, D. Larhammar, R. Quirion, T. Schwartz, and T. Westfall
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
Pharmacol. Rev., March 1, 1998; 50(1): 143 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
R.-X. Wang and L. E. Limbird
Distribution of mRNA Encoding Three alpha 2-Adrenergic Receptor Subtypes in the Developing Mouse Embryo Suggests a Role for the alpha 2A Subtype in Apoptosis
Mol. Pharmacol., December 1, 1997; 52(6): 1071 - 1080.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
L. S. Stone, L. B. MacMillan, K. F. Kitto, L. E. Limbird, and G. L. Wilcox
The alpha 2a Adrenergic Receptor Subtype Mediates Spinal Analgesia Evoked by alpha 2 Agonists and Is Necessary for Spinal Adrenergic-Opioid Synergy
J. Neurosci., September 15, 1997; 17(18): 7157 - 7165.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. P. Lakhlani, L. B. MacMillan, T. Z. Guo, B. A. McCool, D. M. Lovinger, M. Maze, and L. E. Limbird
Substitution of a mutant alpha 2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo
PNAS, September 2, 1997; 94(18): 9950 - 9955.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Wozniak and L. E. Limbird
The Three alpha(2)-Adrenergic Receptor Subtypes Achieve Basolateral Localization in Madin-Darby Canine Kidney II Cells via Different Targeting Mechanisms
J. Biol. Chem., March 1, 1996; 271(9): 5017 - 5024.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. E. Kjeldsen, A. B. Weder, B. Egan, R. Neubig, A. J. Zweifler, and S. Julius
Effect of Circulating Epinephrine on Platelet Function and Hematocrit
Hypertension, May 1, 1995; 25(5): 1096 - 1105.
[Abstract] [Full Text]

Home page
 HypertensionHome page
G. Gong, M. L. Johnson, and W. A. Pettinger
Testosterone Regulation of Renal {alpha}2B-Adrenergic Receptor mRNA Levels
Hypertension, March 1, 1995; 25(3): 350 - 355.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
C. S. Flordellis, M. Berguerand, P. Gouache, Vér. Barbu, H. Gavras, D. E. Handy, G. Béréziat, and J.ël. Masliah
alpha(2)Adrenergic Receptor Subtypes Expressed in Chinese Hamster Ovary Cells Activate Differentially Mitogen-activated Protein Kinase by a p21[IMAGE] Independent Pathway
J. Biol. Chem., February 24, 1995; 270(8): 3491 - 3494.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
F. Grossman, H. K. Manji, and W. Z. Potter
Platelet {alpha}2-adrenoreceptors in depression: a critical examination
J Psychopharmacol, January 1, 1993; 7(1_suppl): 4 - 18.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
K. M. Small, S. L. Forbes, K. M. Brown, and S. B. Liggett
An Asn to Lys Polymorphism in the Third Intracellular Loop of the Human alpha 2A-Adrenergic Receptor Imparts Enhanced Agonist-promoted Gi Coupling
J. Biol. Chem., December 1, 2000; 275(49): 38518 - 38523.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. M. Small, K. M. Brown, S. L. Forbes, and S. B. Liggett
Polymorphic Deletion of Three Intracellular Acidic Residues of the alpha 2B-Adrenergic Receptor Decreases G Protein-coupled Receptor Kinase-mediated Phosphorylation and Desensitization
J. Biol. Chem., February 9, 2001; 276(7): 4917 - 4922.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. G. Richman, A. E. Brady, Q. Wang, J. L. Hensel, R. J. Colbran, and L. E. Limbird
Agonist-regulated Interaction between alpha 2-Adrenergic Receptors and Spinophilin
J. Biol. Chem., April 27, 2001; 276(18): 15003 - 15008.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by The Federation of American Societies for Experimental Biology.